Etretinate therapy for generalized pustular psoriasis in children

Area of Science:

• Dermatology
• Pediatric Medicine
• Pharmacology

Background:

• Pustular psoriasis is a severe skin condition that can be debilitating in children.
• Limited treatment options exist for recalcitrant pediatric pustular psoriasis.
• Etretinate is a retinoid with potential therapeutic benefits for severe dermatological conditions.

Observation:

• Two young children (19 months old) with severe, recalcitrant pustular psoriasis were treated with etretinate.
• Treatment was administered intermittently over a 3.5-year period.
• Comprehensive monitoring included laboratory tests, spinal roentgenograms, and bone age assessments.

Findings:

• Both children experienced remarkable improvement in their pustular psoriasis.
• No apparent adverse effects on growth and development were observed.
• Transient, mild side effects included dry skin, skin fragility, and minor elevations in liver enzymes and triglycerides.

Implications:

• Etretinate therapy presents a viable treatment option for pediatric intractable pustular psoriasis.
• This approach may significantly improve the quality of life for affected children.
• Further research into long-term efficacy and safety in pediatric populations is warranted.